Chonnam National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1993-03-27

Employees: 1K

Market Cap: -

Website: http://www.cnuh.com

Clinical Trials

BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

Phase 2

Completed

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Belotaxel
Drug: Belloxa

First Posted Date: 2010-11-19

Last Posted Date: 2015-08-17

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 33

Registration Number: NCT01243775

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Jeonnam, Korea, Republic of

Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Phase 2

Conditions: Lymphoma, Large B-cell, Diffuse

Interventions: Drug: rituximab

First Posted Date: 2010-08-16

Last Posted Date: 2011-09-22

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 50

Registration Number: NCT01181999

Locations: 🇰🇷
Chonnam National University Hwasun Hosptial, Jeollanam-do, Korea, Republic of

90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell Lymphoma

Phase 2

Completed

Conditions: Lymphoma, Large B-Cell, Diffuse

Interventions: Drug: ibritumomab tiuxetan (Zevalin)

First Posted Date: 2010-07-08

Last Posted Date: 2010-07-08

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 20

Registration Number: NCT01157988

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea, Republic of

Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)

Phase 2

Conditions: Multiple Myeloma

First Posted Date: 2010-04-30

Last Posted Date: 2011-09-22

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 78

Registration Number: NCT01114048

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun-gun, Jeollanam-do, Korea, Republic of

Umbilical Cord Serum Eye Drops

Not Applicable

Completed

Conditions: Recurrent Corneal Erosion

Interventions: Drug: Umbilical cord serum eyedrops

First Posted Date: 2009-11-19

Last Posted Date: 2009-11-19

Lead Sponsor: Chonnam National University Hospital

Registration Number: NCT01016158

Locations: 🇰🇷
Chonnam National University Hospital, Gwang-Ju, Korea, Republic of

Bioequivalence of Rebamipide in Korean

Not Applicable

Completed

Conditions: Therapeutic Equivalency
Pharmacogenetics

Interventions: Drug: Rebamide

First Posted Date: 2009-10-19

Last Posted Date: 2009-10-19

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 30

Registration Number: NCT00997789

Locations: 🇰🇷
Institute of Bioeqivalence and Bridging Study, College of Pharmacy, CNU, Gwangju, Korea, Republic of

CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome

Completed

Conditions: Dry Eye Syndrome

First Posted Date: 2009-10-08

Last Posted Date: 2009-10-08

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 48

Registration Number: NCT00991679

Locations: 🇰🇷
Chonnam National University Hospital, Gwangju, Chonnam, Korea, Republic of

Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia

Interventions: Drug: Paliperidone ER
Drug: Risperidone

First Posted Date: 2009-01-23

Last Posted Date: 2011-12-23

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 58

Registration Number: NCT00827840

Locations: 🇰🇷
Dept. of Psychiatry, Chonnam National Univeristy Hospital, Gwangju, Korea, Republic of

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Phase 3

Completed

Conditions: Carcinoma, Small Cell

Interventions: Drug: Belotecan
Drug: Etoposide
Drug: Cisplatin

First Posted Date: 2009-01-22

Last Posted Date: 2021-08-09

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 147

Registration Number: NCT00826644

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic of

Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Gefitinib retreatment

First Posted Date: 2009-01-19

Last Posted Date: 2013-02-26

Lead Sponsor: Chonnam National University Hospital

Target Recruit Count: 23

Registration Number: NCT00824746

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun-gun, Jeonnam, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy